Page 10 - Nasdaq Tech News Today

Bio-Techne (NASDAQ:TECH – Get Rating) released its quarterly earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. The company had revenue of $294.15 million for the quarter, compared to analyst estimates of $298.55 million. Bio-Techne had a net margin of 24.15% […]

Bio-Techne (NASDAQ:TECH – Get Rating) posted its earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. Bio-Techne had a return on equity of 15.31% and a net margin of 24.15%. The firm had revenue of $294.15 million during the quarter, compared […]

Bio-Techne (NASDAQ:TECH – Get Rating) issued its earnings results on Wednesday. The biotechnology company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. Bio-Techne had a net margin of 24.15% and a return on equity of 15.31%. The business had revenue of $294.15 million during […]

Bio-Techne (NASDAQ:TECH – Get Rating) had its price target upped by Robert W. Baird from $99.00 to $100.00 in a report issued on Thursday, The Fly reports. TECH has been the topic of several other reports. StockNews.com upgraded Bio-Techne from a hold rating to a buy rating in a research report on Wednesday, April 26th. […]

Bio-Techne Co. (NASDAQ:TECH – Get Rating) declared a quarterly dividend on Wednesday, May 3rd, Zacks reports. Stockholders of record on Monday, May 15th will be paid a dividend of 0.08 per share by the biotechnology company on Friday, May 26th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.37%. […]

Fox Run Management L.L.C. acquired a new stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,658 shares of the biotechnology company’s stock, valued at approximately $386,000. Several other hedge funds and other institutional investors have […]

Geneva Capital Management LLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 297.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,059,500 shares of the biotechnology company’s stock after purchasing an additional 793,107 shares during the quarter. Bio-Techne […]

S&CO Inc. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,080 shares of the biotechnology company’s stock after acquiring an additional 19,560 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne […]

Lmcg Investments LLC raised its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,069 shares of the biotechnology company’s stock after buying an additional 11,309 shares during the quarter. Lmcg Investments […]

StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday. TECH has been the topic of several other research reports. Wells Fargo & Company upgraded shares of Bio-Techne from an underweight rating to an equal weight rating and set a […]